Immutable evidence record · ticker
Telomir Pharmaceuticals, Inc. Common Stock (TELO)
Published as observed on 18 August 2026 at 06:46 BST.
Telomir Pharmaceuticals, Inc. Common Stock has a balanced company news read. Its latest completed weekly trend is negative.
- As of
- 18 Aug 2026, 06:46
- Scope
- company and instrument
- Evidence
- 18 items
- Independent sources
- 2
- Country
- United States
- Sector
- Healthcare
- Previous read
- 50.000
- Change
- —
Verification
Evidence & related research
Company chart →Technicals & Market Dynamics →Technical Research Pack →Company news sentiment →Current financial news →
This is dated market research. Coverage may be delayed, incomplete or unavailable.
Cite this record:
Sharemaestro, Telomir Pharmaceuticals, Inc. Common Stock (TELO), 2026-08-18, https://sharemaestro.com/evidence/ad2a4922-7611-4bdd-9cd0-bf1b7e234622/
Record checksum 04cdcfd42925794652f49972f1e5d1257ac4f126cec26664dfdd34ff41ad2808
